Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EuroEyes is a publicly traded ophthalmology services company that operates a network of premium eye clinics focused on refractive vision correction and lens-based procedures. The company provides laser vision correction, implantable collamer lens procedures, trifocal lens exchange for presbyopia, and cataract surgery, and markets itself as a high-end provider of surgical vision correction. Founded in Hamburg, Germany in 1993, EuroEyes has expanded across Germany, Denmark, China, the United Kingdom, Switzerland, and Hong Kong-facing operations. The business is known for its strong position in presbyopia treatment and trifocal lens exchange surgery, including repeated recognition from Carl Zeiss for high volumes of trifocal lens implantations. Unlike a biotech or pharma developer, EuroEyes is primarily a commercial healthcare delivery company rather than a drug-development platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EuroEyes.